Literature DB >> 18669587

Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.

Dong-Hyun Kim1, Keon-Hee Kim, Dae-Hwan Kim, Kwang-Hyeon Liu, Heung-Chae Jung, Jae-Gu Pan, Chul-Ho Yun.   

Abstract

Recently, wild-type and mutant forms of bacterial cytochrome P450 BM3 (CYP102A1) have been found to metabolize various drugs through reactions similar to those catalyzed by human cytochromes P450 (P450s). Therefore, it has been suggested that CYP102A1 may be used to produce large quantities of the metabolites of human P450-catalyzed reactions. In this report, we show that the oxidation of 7-ethoxycoumarin, a typical human P450 substrate, is catalyzed by both wild-type and mutant forms of CYP102A1. Two major products were produced as a result of O-deethylation and 3-hydroxylation reactions. These results demonstrate that CYP102A1 mutants catalyze the same reactions as human P450s. High noncompetitive intermolecular kinetic deuterium isotope effects were observed for 7-ethoxycoumarin O-deethylation in the CYP102A1 system. These results suggest that there is a common mechanism for the oxidation reactions catalyzed by both the bacterial CYP102A1 and human P450 enzymes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669587     DOI: 10.1124/dmd.108.021220

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

1.  Bioproduction of eriodictyol by Escherichia coli engineered co-culture.

Authors:  Nguyen Huy Thuan; Vinay Bharadwaj Tatipamula; Tran Thanh Viet; Nguyen Quang Duc Tien; Nguyen Hoang Loc
Journal:  World J Microbiol Biotechnol       Date:  2022-05-16       Impact factor: 3.312

2.  Methylene Oxidation of Alkyl Sulfates by Cytochrome P450BM-3 and a Role for Conformational Selection in Substrate Recognition.

Authors:  F Peter Guengerich; Mostafa I Fekry
Journal:  ACS Catal       Date:  2020-04-02       Impact factor: 13.084

3.  Chimeric self-sufficient P450cam-RhFRed biocatalysts with broad substrate scope.

Authors:  Aélig Robin; Valentin Köhler; Alison Jones; Afruja Ali; Paul P Kelly; Elaine O'Reilly; Nicholas J Turner; Sabine L Flitsch
Journal:  Beilstein J Org Chem       Date:  2011-11-02       Impact factor: 2.883

4.  Characterization of diverse natural variants of CYP102A1 found within a species of Bacillus megaterium.

Authors:  Ji-Yeon Kang; So-Young Kim; Dooil Kim; Dong-Hyun Kim; Sun-Mi Shin; Sun-Ha Park; Keon-Hee Kim; Heung-Chae Jung; Jae-Gu Pan; Young Hee Joung; Youn-Tae Chi; Ho Zoon Chae; Taeho Ahn; Chul-Ho Yun
Journal:  AMB Express       Date:  2011-03-28       Impact factor: 3.298

5.  Hydroxylation of diverse flavonoids by CYP450 BM3 variants: biosynthesis of eriodictyol from naringenin in whole cells and its biological activities.

Authors:  Luan Luong Chu; Ramesh Prasad Pandey; Narae Jung; Hye Jin Jung; Eun-Hee Kim; Jae Kyung Sohng
Journal:  Microb Cell Fact       Date:  2016-08-05       Impact factor: 5.328

6.  Synthesis of umbelliferone derivatives in Escherichia coli and their biological activities.

Authors:  Luan Luong Chu; Ramesh Prasad Pandey; Haet Nim Lim; Hye Jin Jung; Nguyen Huy Thuan; Tae-Su Kim; Jae Kyung Sohng
Journal:  J Biol Eng       Date:  2017-04-05       Impact factor: 4.355

Review 7.  A Promiscuous Bacterial P450: The Unparalleled Diversity of BM3 in Pharmaceutical Metabolism.

Authors:  Sian Thistlethwaite; Laura N Jeffreys; Hazel M Girvan; Kirsty J McLean; Andrew W Munro
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

Review 8.  Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites.

Authors:  Giovanna Di Nardo; Gianfranco Gilardi
Journal:  Int J Mol Sci       Date:  2012-11-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.